日本調剤(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 小売業 | 3341/E05422 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/01/15 | 日証協 | 109,669株 | -3.45% | 34,600株 | +80.21% | 528,455株 | -1.08% | 11,915株 | -41.31% |
2021/01/08 | 日証協 | 113,589株 | +7.27% | 19,200株 | +143.04% | 534,240株 | +4.06% | 20,301株 | -1.88% |
2020/12/30 | 日証協 | 105,889株 | -2.13% | 7,900株 | -84.96% | 513,387株 | +2.68% | 20,691株 | -70.44% |
2020/12/25 | 日証協 | 108,189株 | +40.71% | 52,544株 | +106.51% | 499,987株 | +11.98% | 70,000株 | +53.51% |
2020/12/18 | 日証協 | 76,889株 | -18.37% | 25,444株 | -50.18% | 446,488株 | +2.76% | 45,600株 | -22.97% |
2020/12/11 | 日証協 | 94,189株 | +31.02% | 51,072株 | +46.91% | 434,508株 | +10.93% | 59,200株 | -30.73% |
2020/12/04 | 日証協 | 71,889株 | -12.45% | 34,764株 | -32.69% | 391,708株 | +15.18% | 85,458株 | -63.96% |
2020/11/27 | 日証協 | 82,115株 | -52.82% | 51,644株 | -63.83% | 340,096株 | +50.37% | 237,107株 | +77.2% |
2020/11/20 | 日証協 | 174,046株 | +77.51% | 142,798株 | +1152.39% | 226,180株 | +43.72% | 133,809株 | +2523.71% |
2020/11/13 | 日証協 | 98,048株 | -5.56% | 11,402株 | -1.26% | 157,380株 | -5.18% | 5,100株 | +95.7% |
2020/11/06 | 日証協 | 103,822株 | +0.58% | 11,548株 | +20.27% | 165,980株 | +0.73% | 2,606株 | -24.9% |
2020/10/30 | 日証協 | 103,222株 | +11.57% | 9,602株 | -70.8% | 164,769株 | +4.07% | 3,470株 | -70.59% |
2020/10/23 | 日証協 | 92,520株 | +6.44% | 32,882株 | +11.09% | 158,330株 | +4.71% | 11,800株 | -35.81% |
2020/10/16 | 日証協 | 86,920株 | -23.05% | 29,600株 | -61.34% | 151,213株 | -12% | 18,383株 | -54.86% |
2020/10/09 | 日証協 | 112,960株 | -12.43% | 76,570株 | -44.35% | 171,830株 | -25.26% | 40,722株 | -62.1% |
2020/10/02 | 日証協 | 128,989株 | +34.66% | 137,600株 | +60.19% | 229,902株 | +19.52% | 107,441株 | +15.47% |
2020/09/25 | 日証協 | 95,789株 | -18.95% | 85,900株 | +51.23% | 192,352株 | +5.48% | 93,050株 | +343.94% |
2020/09/18 | 日証協 | 118,189株 | -11.59% | 56,800株 | -40.77% | 182,352株 | -6.86% | 20,960株 | +31.82% |
2020/09/11 | 日証協 | 133,689株 | -3.67% | 95,900株 | -0.44% | 195,792株 | 0% | 15,900株 | -38.9% |
※株式分割は考慮していませんのでご注意ください。
Page Top